Product Description
| Cat Number | HY-10182G |
|---|---|
| Category | GMP Small Molecule |
| Pack Size | 1 EA |
| Description | Laduviglusib (CHIR-99021) (GMP) is Laduviglusib (HY-10182) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Laduviglusib is a potent, orally active and selective GSK-3α/β inhibitor. |
| Molecular Weight | 465.34 |
| Research Field | Cancer; Metabolic Disease |
| Formula | C22H18Cl2N8 |
| Smiles | N#CC1=CC=C(N=C1)NCCNC2=NC=C(C(C3=CC=C(Cl)C=C3Cl)=N2)C4=NC=C(N4)C |
| Scientific Background | Autophagy;PI3K/Akt/mTOR;Stem Cell/Wnt |
| Storage | Store in a tightly closed, dry and light-resistant container below -15°C |
| View Document | |
| Note | The product is for research use only |
Share Item: